Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Jacobson
M A
MA
Department of Medicine, University of California, San Francisco 94110, USA.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000284:Administration, Oral; D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000077404:Cidofovir; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D003596:Cytosine / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use; D004343:Drug Implants; D004359:Drug Therapy, Combination; D017245:Foscarnet / Q000493:pharmacokinetics / Q000627:therapeutic use; D015774:Ganciclovir / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use
D000998:Antiviral Agents; D004343:Drug Implants; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D017245:Foscarnet; D003596:Cytosine; D000077404:Cidofovir; D015774:Ganciclovir